Global Opioid Induced Constipation Treatment Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

  • receipt Report ID : 150588
  • calendar_today Published On: Apr, 2019
  • file_copy Pages: 123
  • list Pharmaceuticals and Healthcare

There are multiple drugs in the pipeline for opioid induced constipation treatment. Upon approval, these drugs will face little competition in this market which is largely untapped. There have not been many stable choices in the pharmaceutical industry for opioid induced constipation treatment over the recent past, but the continuous approval rate of highly targeted drugs is expected to provide a strong push to this market’s growth rate.

Scope of the Report:

This report studies the Opioid Induced Constipation Treatment market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Opioid Induced Constipation Treatment market by product type and applications/end industries.

The global Opioid Induced Constipation Treatment market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Opioid Induced Constipation Treatment.

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

Market Segment by Companies, this report covers

GlaxoSmithKline

AstraZeneca

Pfizer

S.L.A. Pharma

AIKO Biotechnology

Cubist Pharmaceuticals

Salix Pharmaceuticals

Takeda Pharmaceutical

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Oral

Parenteral (Subcutaneous Injection)

Market Segment by Applications, can be divided into

Drug Store

Independent Pharmacies

Hospital Pharmacies

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents

1 Opioid Induced Constipation Treatment Market Overview

1.1 Product Overview and Scope of Opioid Induced Constipation Treatment

1.2 Classification of Opioid Induced Constipation Treatment by Types

1.2.1 Global Opioid Induced Constipation Treatment Revenue Comparison by Types (2017-2023)

1.2.2 Global Opioid Induced Constipation Treatment Revenue Market Share by Types in 2017

1.2.3 Oral

1.2.4 Parenteral (Subcutaneous Injection)

1.3 Global Opioid Induced Constipation Treatment Market by Application

1.3.1 Global Opioid Induced Constipation Treatment Market Size and Market Share Comparison by Applications (2013-2023)

1.3.2 Drug Store

1.3.3 Independent Pharmacies

1.3.4 Hospital Pharmacies

1.4 Global Opioid Induced Constipation Treatment Market by Regions

1.4.1 Global Opioid Induced Constipation Treatment Market Size (Million USD) Comparison by Regions (2013-2023)

1.4.1 North America (USA, Canada and Mexico) Opioid Induced Constipation Treatment Status and Prospect (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy) Opioid Induced Constipation Treatment Status and Prospect (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Opioid Induced Constipation Treatment Status and Prospect (2013-2023)

1.4.4 South America (Brazil, Argentina, Colombia) Opioid Induced Constipation Treatment Status and Prospect (2013-2023)

1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Opioid Induced Constipation Treatment Status and Prospect (2013-2023)

1.5 Global Market Size of Opioid Induced Constipation Treatment (2013-2023)

2 Manufacturers Profiles

2.1 GlaxoSmithKline

2.1.1 Business Overview

2.1.2 Opioid Induced Constipation Treatment Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 GlaxoSmithKline Opioid Induced Constipation Treatment Revenue, Gross Margin and Market Share (2016-2017)

2.2 AstraZeneca

2.2.1 Business Overview

2.2.2 Opioid Induced Constipation Treatment Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 AstraZeneca Opioid Induced Constipation Treatment Revenue, Gross Margin and Market Share (2016-2017)

2.3 Pfizer

2.3.1 Business Overview

2.3.2 Opioid Induced Constipation Treatment Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Pfizer Opioid Induced Constipation Treatment Revenue, Gross Margin and Market Share (2016-2017)

2.4 S.L.A. Pharma

2.4.1 Business Overview

2.4.2 Opioid Induced Constipation Treatment Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 S.L.A. Pharma Opioid Induced Constipation Treatment Revenue, Gross Margin and Market Share (2016-2017)

2.5 AIKO Biotechnology

2.5.1 Business Overview

2.5.2 Opioid Induced Constipation Treatment Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 AIKO Biotechnology Opioid Induced Constipation Treatment Revenue, Gross Margin and Market Share (2016-2017)

2.6 Cubist Pharmaceuticals

2.6.1 Business Overview

2.6.2 Opioid Induced Constipation Treatment Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Cubist Pharmaceuticals Opioid Induced Constipation Treatment Revenue, Gross Margin and Market Share (2016-2017)

2.7 Salix Pharmaceuticals

2.7.1 Business Overview

2.7.2 Opioid Induced Constipation Treatment Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Salix Pharmaceuticals Opioid Induced Constipation Treatment Revenue, Gross Margin and Market Share (2016-2017)

2.8 Takeda Pharmaceutical

2.8.1 Business Overview

2.8.2 Opioid Induced Constipation Treatment Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Takeda Pharmaceutical Opioid Induced Constipation Treatment Revenue, Gross Margin and Market Share (2016-2017)

3 Global Opioid Induced Constipation Treatment Market Competition, by Players

3.1 Global Opioid Induced Constipation Treatment Revenue and Share by Players (2013-2018)

3.2 Market Concentration Rate

3.2.1 Top 5 Opioid Induced Constipation Treatment Players Market Share

3.2.2 Top 10 Opioid Induced Constipation Treatment Players Market Share

3.3 Market Competition Trend

4 Global Opioid Induced Constipation Treatment Market Size by Regions

4.1 Global Opioid Induced Constipation Treatment Revenue and Market Share by Regions

4.2 North America Opioid Induced Constipation Treatment Revenue and Growth Rate (2013-2018)

4.3 Europe Opioid Induced Constipation Treatment Revenue and Growth Rate (2013-2018)

4.4 Asia-Pacific Opioid Induced Constipation Treatment Revenue and Growth Rate (2013-2018)

4.5 South America Opioid Induced Constipation Treatment Revenue and Growth Rate (2013-2018)

4.6 Middle East and Africa Opioid Induced Constipation Treatment Revenue and Growth Rate (2013-2018)

5 North America Opioid Induced Constipation Treatment Revenue by Countries

5.1 North America Opioid Induced Constipation Treatment Revenue by Countries (2013-2018)

5.2 USA Opioid Induced Constipation Treatment Revenue and Growth Rate (2013-2018)

5.3 Canada Opioid Induced Constipation Treatment Revenue and Growth Rate (2013-2018)

5.4 Mexico Opioid Induced Constipation Treatment Revenue and Growth Rate (2013-2018)

6 Europe Opioid Induced Constipation Treatment Revenue by Countries

6.1 Europe Opioid Induced Constipation Treatment Revenue by Countries (2013-2018)

6.2 Germany Opioid Induced Constipation Treatment Revenue and Growth Rate (2013-2018)

6.3 UK Opioid Induced Constipation Treatment Revenue and Growth Rate (2013-2018)

6.4 France Opioid Induced Constipation Treatment Revenue and Growth Rate (2013-2018)

6.5 Russia Opioid Induced Constipation Treatment Revenue and Growth Rate (2013-2018)

6.6 Italy Opioid Induced Constipation Treatment Revenue and Growth Rate (2013-2018)

7 Asia-Pacific Opioid Induced Constipation Treatment Revenue by Countries

7.1 Asia-Pacific Opioid Induced Constipation Treatment Revenue by Countries (2013-2018)

7.2 China Opioid Induced Constipation Treatment Revenue and Growth Rate (2013-2018)

7.3 Japan Opioid Induced Constipation Treatment Revenue and Growth Rate (2013-2018)

7.4 Korea Opioid Induced Constipation Treatment Revenue and Growth Rate (2013-2018)

7.5 India Opioid Induced Constipation Treatment Revenue and Growth Rate (2013-2018)

7.6 Southeast Asia Opioid Induced Constipation Treatment Revenue and Growth Rate (2013-2018)

8 South America Opioid Induced Constipation Treatment Revenue by Countries

8.1 South America Opioid Induced Constipation Treatment Revenue by Countries (2013-2018)

8.2 Brazil Opioid Induced Constipation Treatment Revenue and Growth Rate (2013-2018)

8.3 Argentina Opioid Induced Constipation Treatment Revenue and Growth Rate (2013-2018)

8.4 Colombia Opioid Induced Constipation Treatment Revenue and Growth Rate (2013-2018)

9 Middle East and Africa Revenue Opioid Induced Constipation Treatment by Countries

9.1 Middle East and Africa Opioid Induced Constipation Treatment Revenue by Countries (2013-2018)

9.2 Saudi Arabia Opioid Induced Constipation Treatment Revenue and Growth Rate (2013-2018)

9.3 UAE Opioid Induced Constipation Treatment Revenue and Growth Rate (2013-2018)

9.4 Egypt Opioid Induced Constipation Treatment Revenue and Growth Rate (2013-2018)

9.5 Nigeria Opioid Induced Constipation Treatment Revenue and Growth Rate (2013-2018)

9.6 South Africa Opioid Induced Constipation Treatment Revenue and Growth Rate (2013-2018)

10 Global Opioid Induced Constipation Treatment Market Segment by Type

10.1 Global Opioid Induced Constipation Treatment Revenue and Market Share by Type (2013-2018)

10.2 Global Opioid Induced Constipation Treatment Market Forecast by Type (2018-2023)

10.3 Oral Revenue Growth Rate (2013-2023)

10.4 Parenteral (Subcutaneous Injection) Revenue Growth Rate (2013-2023)

11 Global Opioid Induced Constipation Treatment Market Segment by Application

11.1 Global Opioid Induced Constipation Treatment Revenue Market Share by Application (2013-2018)

11.2 Opioid Induced Constipation Treatment Market Forecast by Application (2018-2023)

11.3 Drug Store Revenue Growth (2013-2018)

11.4 Independent Pharmacies Revenue Growth (2013-2018)

11.5 Hospital Pharmacies Revenue Growth (2013-2018)

12 Global Opioid Induced Constipation Treatment Market Size Forecast (2018-2023)

12.1 Global Opioid Induced Constipation Treatment Market Size Forecast (2018-2023)

12.2 Global Opioid Induced Constipation Treatment Market Forecast by Regions (2018-2023)

12.3 North America Opioid Induced Constipation Treatment Revenue Market Forecast (2018-2023)

12.4 Europe Opioid Induced Constipation Treatment Revenue Market Forecast (2018-2023)

12.5 Asia-Pacific Opioid Induced Constipation Treatment Revenue Market Forecast (2018-2023)

12.6 South America Opioid Induced Constipation Treatment Revenue Market Forecast (2018-2023)

12.7 Middle East and Africa Opioid Induced Constipation Treatment Revenue Market Forecast (2018-2023)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Data Source

List of Tables and Figures

Figure Opioid Induced Constipation Treatment Picture

Table Product Specifications of Opioid Induced Constipation Treatment

Table Global Opioid Induced Constipation Treatmen

Please fill the form below, to recieve the report sample


+1

Choose License Type

Reach Us

Email us at

sales@mrinsights.biz

Or call us on

US +1-201-465-4211

IND +91-906-779-0957

Why Choose Us

ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems

Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system

Global Outreach6 Major regions and 40+ countries level analysis accomplished

Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery